News for TransMedics Group, Inc. (TMDX)

TransMedics Group, Inc. (NASDAQ:TMDX) Q2 2025 Earnings Conference Call July 30, 2025 4:30 PM ETCompany ParticipantsWaleed Hassanein - Founder, President,...

September S&P 500 E-Mini futures (ESU25) are up +0.04%, and September Nasdaq 100 E-Mini futures (NQU25) are up +0.10% this morning, pointing to a cautious open on Wall Street as investors await the Federal Reserve’s policy decision, a fresh batch of U.S. economic data, including the ADP employment report and the first estimate of second-quarter GDP, as well as earnings reports from “Magnificent Seven” companies Microsoft and Meta.

In the current session, TransMedics Group Inc. TMDX is trading at $103.90, after a 5.44% drop. Over the past month, the stock fell by 21.67%, and in the past ye...

TransMedics (TMDX) to release Q2 2025 financial results on July 30, 2025. The earnings call is scheduled for 4:30 p.m. ET / 1:30 p.m. PT. Investors c

On July 15, 2025, Canaccord Genuity analyst William Plovanic announced an updated price target for TransMedics Group (TMDX), raising its target from $129.00 to

Headwaters Capital Management, an investment management company, released its second-quarter 2025 investor letter. A copy of the letter can be downloaded here. The portfolio bounced back from the first quarter uncertainty and, like the rest of the market, experienced a strong rebound after the tariff-induced sell-off at the start of the quarter. The portfolio gained […]

An analysis by Canaccord, led by William Plovanic, has resulted in an uptick of the price target for TransMedics (TMDX) from $129 to $142, while maintaining a B

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies. The RSI is a momentum indicator, which compares a...

TransMedics has rebounded from a sharp sell-off by consistently beating guidance and demonstrating strong execution. Read why TMDX stock is a Buy.

U.S. stocks traded mostly lower toward the end of trading, with the Dow Jones index dipping more than 250 points on Friday. The Dow traded down 0.60% to 44,382...

Shares of TransMedics Group Inc (TMDX) fell 9.50% in mid-day trading on Jul 11. The stock reached an intraday low of $109.59, before recovering slightly to $1

Shares of TransMedics Group Inc (TMDX) fell 4.30% in mid-day trading on Jul 7. The stock reached an intraday low of $123.25, before recovering slightly to $12

SAN DIEGO, July 03, 2025 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP is investigating potential violations of federal and state laws by certain officers of the

The healthcare sector offers an abundance of high-growth investment opportunities. Companies leveraging artificial intelligence and genomic medicine are delivering innovative therapies with significant potential. Here are 10 under-the-radar healthcare stocks that could be great buys for your portfolio.

Shares of TransMedics Group Inc (TMDX) fell 8.65% in mid-day trading on Jun 18. The stock reached an intraday low of $124.00, before recovering slightly to $1

In the latest analyst update, TransMedics Group (TMDX) received a revised price target from investment firm Oppenheimer. Analyst Suraj Kalia has increased the p

Growth stocks are companies that are expected to report above-average earnings and revenue growth.

Oppenheimer has increased its price target for TransMedics (TMDX) from $130 to $150, while maintaining an Outperform rating on the stock. This adjustment comes

On June 17, 2025, Needham analyst Mike Matson reaffirmed a "Hold" rating for TransMedics Group (TMDX). This decision marks a continuation of the previously set